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Purpose: To determine the walking economy before and after the onset of claudication pain in patients with peripheral arterial
disease (PAD), and to identify predictors of the change in walking economy following the onset of claudication pain.
Methods: A total of 39 patients with PAD were studied, in which 29 experienced claudication (Pain group) during a
constant load, walking economy treadmill test (speed  2.0 mph, grade  0%) and 10 were pain-free during this test
(Pain-Free group). Patients were characterized on walking economy (ie, oxygen uptake during ambulation), as well as on
demographic characteristics, cardiovascular risk factors, baseline exercise performance measures, and the ischemic
window calculated from the decrease in ankle systolic blood pressure following exercise.
Results: During the constant load treadmill test, the Pain group experienced onset of claudication pain at 323 195 seconds
(mean standard deviation) and continued to walk until maximal pain was attained at 759 332 seconds.Walking economy
during pain-free ambulation (9.54  1.42 ml · kg1 · min1) changed (P < .001) after the onset of pain (10.18  1.56
ml · kg1 · min1). The change in walking economy after the onset of pain was associated with ischemic window (P< .001),
hypertension (P< .001), diabetes (P .002), and height (P .003). In contrast, the Pain-Free groupwalked pain-free for the
entire 20-minute test duration without a change in walking economy (P  .36) from the second minute of exercise (9.20 
1.62 ml · kg1 · min1) to the nineteenth minute of exercise (9.07  1.54 ml · kg1 · min1).
Conclusion: Painful ambulation at a constant speed is associated with impaired walking economy, as measured by an
increase in oxygen uptake in patients limited by intermittent claudication, and the change in walking economy is
explained, in part, by severity of PAD, diabetes, and hypertension. (J Vasc Surg 2010;51:628-33.)Intermittent claudication is a symptom of peripheral
arterial disease (PAD), and is associated with elevated rates
of mortality1-4 and morbidity.5 Intermittent claudication
afflicts 5% of the US population older than 55 years of age,6
and occurs during ambulation when the peripheral circula-
tion is inadequate tomeet themetabolic requirement of the
active leg musculature. Thus, intermittent claudication im-
pairs ambulation,7,8 daily physical activity,9 and health-
related quality of life.10
Walking economy, defined as the oxygen uptake during
ambulation, is a key aspect in sustaining ambulatory activi-
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628ties.11 Patients with intermittent claudication have poor walk-
ing economy, as their oxygen uptake of pain-free ambulation
is higher than age-matched controls.11 This may be a conse-
quence of an altered gait pattern observed even before the
development of claudication pain,12-14 but this is not a con-
sistent finding.15-17When the impaired walking economy (ie,
highoxygenuptake) of patientswith intermittent claudication
is considered along with their low peak oxygen uptake,18-20
pain-free ambulation at any given pace is performed at a
higher relative metabolic cost than compared with controls.11
The onset of claudication may impair walking economy even
further, thereby increasing the relative metabolic cost of pain-
ful ambulation and reducing exercise tolerance of patients
with intermittent claudication. However, surprisingly no in-
formation is available comparing the walking economy while
ambulating pain-free and with leg pain.
Therefore, the purpose of our study was to determine
the walking economy before and after the onset of claudi-
cation pain in patients with PAD, and to identify predictors
of the change in walking economy following the onset of
claudication pain. The hypotheses were that walking econ-
omyworsens (ie, oxygen uptake is increased) after the onset
of claudication pain, and that the severity of PAD is predic-
tive of the change in walking economy.
METHODS
Subjects
Recruitment. Patients were evaluated in the General
Clinical Research Center at the University of Oklahoma
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referrals from the HSC vascular clinic, as well as by news-
paper advertisements for possible enrollment into an exer-
cise study. The procedures used in this study were approved
by the Institutional Review Board at the University of
Oklahoma HSC. Written informed consent was obtained
from each subject prior to investigation.
Screening. Patients with intermittent claudication sec-
ondary to vascular insufficiency were included in this study
if they met the following criteria: (a) a history of intermit-
tent claudication; (b) ambulation during a graded treadmill
test limited by intermittent claudication;7 (c) an ankle-
brachial index (ABI)0.90 at rest;6 or an ABI0.73 after
exercise;21 and (d) for those experiencing pain during the
constant load, walking economy treadmill test (Pain group),
at least one minute of oxygen uptake data was necessary
during both pain-free and painful ambulation to compare
the two conditions. Patients were excluded from this study
for the following conditions: (a) absence of PAD (ABI
0.90 at rest and ABI0.73 after exercise); (b) inability to
obtain an ABImeasure due to non-compressible vessels; (c)
asymptomatic PAD determined from the medical history
and verified during the graded treadmill test; (d) use of
medications indicated for the treatment of intermittent
claudication (cilostazol and pentoxifylline) initiated within
three months prior to investigation; (e) exercise tolerance
limited by factors other than leg pain (eg, severe coronary
artery disease, dyspnea, poorly controlled blood pressure);
and (f) active cancer, renal disease, or liver disease. A total of
80 patients were evaluated for this study, and 39 patients
were deemed eligible.
Measurements
All of the measurements described below were part of
an overall baseline evaluation.
Medical history, physical examination, and anthro-
pometry. Demographic information, height, weight, body
mass index (BMI), waist and hip circumferences,22 cardio-
vascular risk factors, co-morbid conditions, claudication
history, blood samples, and a list of current medications
were obtained from a medical history and physical exami-
nation at the beginning of the study.
Walking impairment questionnaire (WIQ). Self-
reported ambulatory ability was assessed using a validated
questionnaire for PAD patients that assesses ability to walk
at various speeds and distances, and to climb stairs.23
Graded treadmill test.
Claudication times and peak oxygen uptake. Patients
performed a progressive, graded treadmill protocol to de-
termine study eligibility, as well as to obtain outcome
measures related to peak exercise performance.7 The clau-
dication onset time (COT), defined as the walking time at
which the patient first experienced pain, and the peak
walking time (PWT), defined as the walking time at which
ambulation could not continue due to maximal pain, were
both recorded to quantify the severity of claudication. Peak
oxygen uptake was measured by oxygen uptake obtainedduring the peak exercise work load with aMedical Graphics
VO2000 metabolic system (Medical Graphics Inc., St.
Paul, Minn). Using these procedures, the test-retest intra-
class reliability coefficient is R 0.89 for COT,7 R 0.93
for PWT,7 and R  0.88 for peak oxygen uptake.24
ABI and ischemic window. As previously described,
ABI measures were obtained from the more severely dis-
eased lower extremity before and 1, 3, 5, and 7 minutes
after the treadmill test.7,25 The reduction in ankle systolic
blood pressure after treadmill exercise from the resting
baseline value was quantified by calculating the area under
the curve, referred to as the ischemic window.26 Because
the ischemic window is a function of both PAD severity
and the amount of exercise performed, the ischemic win-
dow was normalized per meter walked.
Six-minute walk test. Patients performed an over
ground, six-minute walk test supervised by trained exercise
technicians.27 The pain-free and total distance walked dur-
ing the test were recorded. The test-retest intraclass reliabil-
ity coefficient is R 0.75 for distance to onset of claudica-
tion pain, and R  0.94 for total six-minute walking
distance.27
Ambulatory activity monitoring. Daily ambulatory
activity was assessed using a step activity monitor (Step
Watch 3; Cyma Inc, Mountlake Terrace, Wash) as previ-
ously described.28 Ambulatory activity was measured dur-
ing seven consecutive days in which patients were in-
structed to wear the monitor during waking hours and to
remove it before retiring to bed. The step activity monitor
was attached to the right ankle above the lateral malleolus
using elastic Velcro straps, and continuously recorded the
number of steps taken on a minute-to-minute basis. The
accuracy of the step activity monitor exceeds 99%  1% in
patients with intermittent claudication.28
Walking economy treadmill test. This test was the
experimental protocol used to obtain the two primary
outcome measures consisting of walking economy (oxygen
uptake expressed as ml · kg1 · min1) and the change in
walking economy ( in oxygen uptake expressed as 
ml · kg1 · min1) following the onset of claudication
pain. Additionally, this test was used to group patients into
a Pain group and a Pain-Free group as described in the
results section. Patients performed the walking economy
treadmill test in which the work rate was at a constant speed
of 2 mph and a grade of 0% until maximal claudication pain
was attained, or for a maximum of 20 minutes.29 Oxygen
uptake was measured throughout the test with a Medical
Graphics VO2000 metabolic system. During the test, pa-
tients indicated when they experienced the onset of claudi-
cation pain, and if the pain increased to a maximal level
forcing them to discontinue exercise. Oxygen uptake was
recorded each minute during the test. Data obtained dur-
ing the first and last minute of exercise were not used for
analyses because of the possibility that data was not re-
corded for a full 60 seconds during these time points, and
because the oxygen uptake does not approach a steady-state
value during the first minute. Additionally, oxygen uptake
obtained during the minute in which the onset of claudica-
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because it was not possible to precisely separate the data
before and after the onset of pain within the minute.
Walking economy was calculated as the average oxygen
uptake from the entire test. The change in walking econ-
omy was calculated as the difference in average oxygen
uptake during pain-free and painful ambulation in the Pain
group, and between the second minute and 19th minute of
exercise in the Pain-Free group.
Statistical analyses
A paired t test was used to compare the mean change in
walking economy following the onset of claudication pain
in the patients in the Pain group, and between the two and
nineteenminute time points in the patients in the Pain-Free
group. The Pearson correlation coefficient was estimated to
summarize the correlation between continuous clinical
characteristics or baseline exercise performance with walk-
ing economy measures. Mean walking economy measures
were compared between the two groups of patients using a
two sample t test. Linear regression was used to identify
clinical and baseline exercise performance measures that
were independently correlated with walking economymea-
sures. The measures that were correlated with the walking
economy measures univariately at a 0.10 alpha level were
entered into a multiple linear regression model. These
measures were deleted from the multiple regression model
until all terms were significant at the 0.05 alpha level. The
clinical and baseline exercise performance measures that
were considered in the modeling were age, sex, height,
weight, BMI, ABI, ischemic window, COT, PWT, peak
oxygen uptake, daily ambulatory activity, current smoking,
obesity, abdominal obesity, hypertension, and diabetes. A
separate regression model was fit for walking economy and
the change in walking economy. All analyses were performed
using the SAS statistical package (System for Windows, ver-
sion 9.1, SAS Institute Inc., Cary, NC).
RESULTS
Patients were grouped according to whether they ex-
perienced claudication during the relatively low demanding
walking economy treadmill test. During this test, 29 pa-
tients experienced claudication (Pain group) and 10 did not
experience claudication (Pain-Free group).
The clinical characteristics of the Pain and Pain-Free
groups were similar (P  .05), except for a non-significant
trend (P .059) of a lower ABI in the Pain group (Table I).
Baseline measures of exercise performance were worse in
the Pain group, as they had lower values for COT (P 
.009), PWT (P .001), six-minute walk pain-free distance
(P  .019) and total distance (P  .023), WIQ walking
distance score (P  .001), WIQ walking speed score (P 
.001), WIQ stair climbing score (P  .001), and daily
ambulatory activity (P  .036; Table II).
The walking economy values of the two groups are
shown in Table III. In this study, the average time to the
onset of pain in the Pain group was 323 seconds, and they
continued to walk until maximal pain was attained at anaverage time of 759 seconds. All patients in the Pain-Free
group completed 20minutes of walking without experienc-
ing claudication. The walking economy value increased in
the Pain group after the onset of claudication pain (P 
.001), whereas no change (P  .36) was observed in the
Pain-Free group between the second and 19th minute of
Table I. Clinical characteristics of the pain group and the
pain-free group
Pain group
(n  29)
mean (SD)
Pain-free
group
(n  10)
mean (SD)
P
value
Age (years) 68 (11) 72 (12) .32
Weight (kg) 83.5 (16.5) 81.4 (7.5) .58
Height (cm) 169.8 (8.8) 173.8 (9.9) .24
Body mass index (kg/m2) 29.0 (5.3) 27.2 (3.8) .32
Waist girth (cm) (n  20,
n  7) 98.6 (12.6) 99.6 (6.4) .84
Ankle/brachial index 0.73 (0.20) 0.88 (0.22) .059
Gender (% men) 59% 80% .28
Race (% Caucasian) 59% 70% .71
Current smoking (%) 31% 20% .69
Diabetes (%) 28% 30% .99
Hypertension (%) 86% 100% .56
Dyslipidemia (%) 79% 90% .65
Abdominal obesity (%)
(n  20, n  7) 60% 43% .66
Obesity (%) 41% 10% .12
Bilateral Disease (%)
(n  24, n  9) 63% 44% .44
Medication (%)
Statin 52% 70% .46
Aspirin 69% 90% .40
Plavix 21% 20% 1.00
Table II. Baseline exercise performance measures of the
pain group and the pain-free group
Pain group
(n  29)
Pain-free
group
(n  10)
P
value
Claudication onset time
(sec) 253 (155) 568 (277) .009
Peak walking time (sec) 580 (200) 991 (248) .001
Peak oxygen uptake
(ml · kg1 · min1) 13.8 (3.1) 17.8 (5.5) .086
Ischemic window
(mmHg · min1 · m1) 0.28 (0.36) 0.23 (0.22) .74
6-min walk pain-free
distance (m) 178.5 (86.9) 326.8 (150.2) .019
6-min walk distance (m) 397.0 (75.0) 460.3 (47.2) .023
WIQ distance score (%) 49 (30) 85 (18) .001
WIQ speed score (%) 37 (20) 70 (15) .001
WIQ stair climbing
score (%) 49 (28) 83 (13) .001
Daily ambulatory activity
(steps/day) 2654 (1380) 3767 (1294) .036
WIQ, Walking impairment questionnaire.
Values are means (SD).the treadmill test.
oxyge
inute
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with baseline peak oxygen uptake (r 0.51, P .004), and
with diabetes (P .046; Table IV). Using multiple regres-
sion procedures (Table V), baseline peak oxygen uptake
(P .005) was the only predictor of walking economy. The
change in walking economy following the onset of claudi-
cation was correlated with ischemic window (P  .027),
ABI (P  .037) and diabetes (P  .007). With multiple
regression procedures, the change in walking economy
following onset of claudication was predicted by ischemic
window (P  .001), hypertension (P  .001), diabetes
(P  .002), and height (P  .003).
DISCUSSION
The major findings of this investigation are that (1)
development of claudication pain while ambulating at a
constant speed is associated with impaired walking econ-
omy, as measured by an increase in oxygen uptake, and (2)
the change in walking economy with claudication pain is
primarily related to the ischemic window, diabetes, and
Table III. Walking economy of the pain group (n  29)
Groups
Pain-free
ambulation
Pain
ambul
Pain group walking economy
(ml · kg1 · min1) 9.54 (1.42) 10.18 (
Pain-free group walking economy
(ml · kg1 · min1)* 9.20 (1.62) 9.07 (
Values are means (SD).
*The value for the pain-free group listed under pain-free ambulation is the
under painful ambulation is the oxygen uptake measured during the 19th m
Table IV. The association between walking economy and
Variables
Continuous measures (values are Pearson correlation coefficients)
Age
Height
Weight
Body mass index
Ankle-brachial index
Ischemic window
6-minute walk pain-free distance
6-minute walk distance
Peak oxygen uptake
Daily ambulatory activity
Categorical measures (values are difference in mean VO2)
Gender (male-female)
Current smoking (current-former/never)
Obesity (obese-non-obese)
Abdominal obesity (obese-non-obese)
Hypertension (hypertense–non-hypertense)
Diabetes (diabetic-non-diabetic)
Bilateral disease (bilateral-unilateral)
*P  .05.
**P  .01.hypertension.Walking economy worsened after the onset of claudica-
tion pain in patients ambulating at a constant work rate, with
patients having more severe PAD, as measured by lower
ABI and higher ischemic window, experiencing the greater
changes in walking economy. Although this study does not
address mechanisms for the changes in walking economy, it
has been observed that a gradual increase in oxygen uptake
occurs during severe exercise compared with light exercise,
thus preventing oxygen uptake from reaching a steady-state
plateau during exercise at a constant work load.30 After the
onset of pain, an increase in oxygen uptake may be exagger-
ated in patients with greater severity of PAD because a given
exercise work load becomes relatively more difficult to per-
form than for those with mild PAD. Another possible reason
why patients with more severe PAD have worse walking
economy after the onset of pain is that theymay have a greater
recruitment of fast-twitch motor units, which would increase
oxygen uptake during exercise.31,32 Muscle denervation ob-
served in PAD patients33 may impair optimal motor unit
recruitment during a constant load exercise task, becoming
ain-free group (n  10)
 (painful–pain-free)
ambulation
95% CI for mean
change
P value
for 
0.64 (0.83) 0.32 to 0.96 .001
0.13 (0.44) 0.45 to 0.18 0.36
n uptake measured during the 2nd minute of walking, and the value listed
of walking.
cal characteristics of patients in the pain group (n  29)
Walking economy
(ml · kg1 · min1)
Walking economy: painful–pain-free
ambulation (ml · kg1 · min1)
0.34 0.05
0.06 0.29
0.05 0.20
0.10 0.03
0.15 0.39*
0.18 0.41*
0.03 0.03
0.21 0.15
0.51** 0.090
0.15 0.22
0.36 0.49
0.51 0.33
0.22 0.07
0.04 0.39
0.81 0.76
1.20* 0.89**
0.58 0.048and p
ful
ation
1.56)
1.54)clinimore evident in patients with greater severity of PAD.
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change in walking economy after the onset of pain, as
patients with diabetes had a blunted increase in oxygen
uptake, whereas patients with hypertension had a greater
increase. Diabetes slows whole-body as well as leg skeletal
muscle oxygen uptake kinetics during exercise,34,35 and
may compromise perfusion in more distal portions of the
leg, which may partially explain the blunted increase in
oxygen uptake after onset of pain in patients with diabetes.
Conversely, hypertension increases the perfusion of the calf
musculature,36 which may increase oxygen uptake during
exercise in patients with intermittent claudication.
Walking economy during ambulation represents the
metabolic cost of exercise. Less economical walking, mea-
sured by higher oxygen uptake at a constant work rate,
indicates that exercise is performed at a higher percentage
of exercise capacity, thereby reducing the tolerance to
sustain ambulation.11 Although patients with intermittent
claudication have impaired walking economy than controls
for numerous possible reasons, such as inefficient gait,11
other factors may paradoxically decrease oxygen uptake
during ambulation. In our study, diabetes and low peak
oxygen uptake were associated with better walking econ-
omy (ie, lower oxygen uptake) than in patients without
diabetes and in patients with higher peak oxygen uptake.
Rather than considering patients with diabetes and poor
cardiopulmonary fitness as having favorable walking econ-
omy, the more likely interpretation is that these patients
have impaired ability to increase oxygen uptake to meet the
metabolic demand of exercise. This interpretation is con-
sistent with previous work showing that diabetics have
impaired oxygen uptake kinetics during exercise.34,35 Col-
lectively, the overall net negative effect of PAD on walking
economy (ie, increased oxygen uptake) is partially masked
in patients with diabetes and poor cardiopulmonary fitness.
Therefore, walking economy data should be adjusted for
diabetes and peak oxygen uptake for more valid compari-
Table V. Multiple regression models predicting walking e
onset of claudication in patients in the pain group (n  29
Dependent variables Independent variables
U
Re
co
Walking economy
(ml · kg1 · min1)*
Peak oxygen uptake
(ml · kg1 · min1)
Walking economy:
painful–pain-free ambulation
(ml · kg1 · min1)**
Ischemic window
(mmHg · min1 · m1)
Hypertension
Diabetes 
Height (cm)
*Overall model results: F-test statistic  9.66 with (1, 27) degrees of freed
**Overall model results: F-test statistic  13.38 with (4, 24) degrees of fre
†Standardized regression coefficients were calculated by fitting a linear regres
sample mean and dividing by the sample standard deviation) and represent t
1 standard deviation difference in the independent variable.
††The reference group for each unstandardized coefficient for the indicato
subjects, respectively).sons between patients or groups of patients.Walking economy is one of themechanisms for improv-
ing claudication distances following exercise training.29
Our primary finding of impaired walking economy with
the onset of pain has important clinical implications be-
cause higher oxygen cost during painful ambulation in-
creases the intensity of exercise,11 which may reduce exer-
cise tolerance and limit the amount of work that can be
performed during exercise training sessions. Consequently,
an exercise program that primarily consists of pain-free
ambulation may be a preferable alternative to train patients
than having them walk to a moderate amount of claudica-
tion pain. Indeed, a recent report from our laboratory
found that there is no additional benefit of training patients
at relatively high exercise intensity (80% of maximum work
load) in which a greater amount of painful ambulation is
performed than compared with training at relatively low
intensity (40% of maximum work load) to improve claudi-
cation distances.37
There are several limitations to this study. The correla-
tion and regression coefficients calculated between walking
economy measures and clinical characteristics and baseline
exercise performance measures from this cross-sectional
design do not allow causality to be established. The present
findings are also limited by the relatively small sample sizes,
particularly in the Pain-Free group. Additionally, this study
is limited to PAD patients who have intermittent claudica-
tion, andmay not be generalized to patients with less severe
or more severe PAD. However, the patients in the current
study are typical of patients with intermittent claudication,
as there was a good proportion of women and African-
Americans, and high prevalence of cardiovascular risk fac-
tors for PAD, including smoking, diabetes, hypertension,
dyslipidemia, and obesity. Thus, the findings of the present
study appear generalizable to patients with intermittent
claudication who typically have numerous co-morbid con-
ditions.
In conclusion, painful ambulation at a constant speed is
my, and the change in walking economy following the
ndardized coefficients Standardized coefficients
†
P value
on
nt
95% confidence
interval
Regression
coefficient
95% confidence
interval
0.08 to 0.40 0.51 0.17 to 0.86 .004
0.66 to 1.84 0.54 0.29 to 0.80 .001
†
0.56 to 1.74 0.48 0.24 to 0.73 .001
†
1.21 to 0.32 0.42 0.66 to 0.17 .002
0.014 to 0.059 0.38 0.15 to 0.62 .003
 .004; R2  0.26.
; P  .001; R2  0.69.
odel to standardized independent and dependent variables (subtracting the
ected difference, in standard deviations, in the mean dependent variable per
ables is the group without the condition (normotensive and non-diabeticcono
)
nsta
gressi
efficie
0.24
1.25
1.15
†
0.76
†
0.036
om; P
edom
sion m
he exp
r variassociated with impaired walking economy, as measured by
JOURNAL OF VASCULAR SURGERY
Volume 51, Number 3 Gardner et al 633an increase in oxygen uptake in patients limited by inter-
mittent claudication, and the change in walking economy is
explained, in part, by severity of PAD, diabetes, and hyper-
tension.
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